In transplantable chemically induced sarcoma and genetically engineered sarcoma models expressing immunodominant antigens, CD8+ T cells recognized epitopes corresponding to neoantigens in rejected tumors (225, 226). This evidence concerns the gene CD8A and sarcoma.